TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Recipharm AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
714,735
|
563,230
|
241,732 |
Financial expenses |
6,615,094
|
3,242,919
|
1,597,182 |
Earnings before taxes |
-8,924,910
|
-19,946
|
76,856 |
EBITDA |
-310,489
|
-166,861
|
-242,470 |
Total assets |
23,246,205
|
27,913,303
|
16,937,864 |
Current assets |
13,186,643
|
3,759,869
|
2,434,628 |
Current liabilities |
4,456,780
|
2,000,099
|
1,621,819 |
Equity capital |
9,282,627
|
17,011,576
|
6,891,674 |
- share capital |
51,217
|
47,823
|
49,305 |
Employees (average) |
60
|
67
|
64 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
39.9%
|
60.9%
|
40.7% |
Turnover per employee |
11,912
|
8,406
|
3,777 |
Profit as a percentage of turnover |
-1248.7%
|
-3.5%
|
31.8% |
Return on assets (ROA) |
-9.9%
|
11.5%
|
9.9% |
Current ratio |
295.9%
|
188.0%
|
150.1% |
Return on equity (ROE) |
-96.1%
|
-0.1%
|
1.1% |
Change turnover |
111,540
|
328,763
|
-10,552,612 |
Change turnover % |
18%
|
140% | |
Chg. No. of employees |
-7
|
3
|
-7,793 |
Chg. No. of employees % |
-10%
|
5% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.